topic:"Mesothelioma" found 12 records - Provincial Hospitals Library Catalogue

100 questions and answers about mesothelioma

https://libcat.nshealth.ca/en/permalink/provcat22016

Pass, Harvey I. --Sudbury, MA: Jones and Bartlett , 2005.

Call Number: QZ 340 P285o 2005

Location: Halifax Infirmary

Call Number: QZ 340 P285o 2005

Author: Pass, Harvey I

Other Authors: Roy, Laura; Vento, Susan

Alternate Title: One hundred questions and answers about mesothelioma

Place of Publication: Sudbury, MA

Publisher: Jones and Bartlett

Date of Publication: 2005

Physical Description: 144 p.

Series Title: 100 questions & answers

ISBN: 0763748390

Subjects (MeSH): Mesothelioma - popular works

Format: Book

Location: Halifax Infirmary

Loan Period: 3 weeks

Advances in peritoneal surface oncology

https://libcat.nshealth.ca/en/permalink/provcat30092

--Berlin, Heidelberg: Springer-Verlag , c2007.

Available Online: View e-Book

Location: Online

Available Online: View e-Book

Other Authors: González-Moreno, Santiago

Place of Publication: Berlin, Heidelberg

Publisher: Springer-Verlag

Date of Publication: c2007

Series Vol.: 169

Series Title: Resent results in cancer research

ISBN: 9783540307600

Subjects (MeSH): Carcinoma - therapy; Mesothelioma - therapy; Peritoneal Neoplasms - drug therapy; Peritoneal Neoplasms - surgery

Subjects (LCSH): Oncology; Abdomen - Surgery

Format: e-Book

Location: Online

Asbestos and Mesothelioma

https://libcat.nshealth.ca/en/permalink/provcat41725

Joseph R. Testa, editor. --Cham: Springer , 2017.

Available Online: View e-Book

Location: Online

This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma. Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included. Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothe…

Available Online: View e-Book

Other Authors: Testa, Joseph R.

Responsibility: Joseph R. Testa, editor

Place of Publication: Cham

Publisher: Springer

Date of Publication: 2017

Physical Description: 1 online resource (viii, 407 pages) : 65 illus., 43 illus. in color

Series Title: Current cancer research

ISBN: 9783319535609; 9783319535586 (print ed.)

ISSN: 2199-2584

Subjects (MeSH): Asbestos - adverse effects; Mesothelioma - etiology; Mesothelioma - genetics; Mesothelioma - therapy

Abstract: This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma. Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included. Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothelioma causation, as well as recent research about gene signatures, cell signaling, and epigenetic mechanisms in asbestos-related diseases. Other chapters provide updates of novel disease biomarkers and prevention, mechanistic lesson from genetically engineered mouse and 3-D models of mesothelioma tumorigenesis and therapeutic resistance. Also included are up-to-date reviews of surgical, molecularly targeted chemotherapeutic, and immunotherapeutic approaches for mesothelioma as well as an overview of legal issues.

Contents: 1. Malignant Mesothelioma: An Asbestos Legacy -- 2. Asbestos and Fibrous Erionite -- 3. Epidemiology of Mesothelioma -- 4. Malignant Pleural Mesothelioma: History, Controversy and Future of a Man-Made Epidemic -- 5. Communities at High Risk in the Third Wave of Mesothelioma -- 6. Mesothelioma Pathology -- 7. Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases -- 8. Germline and Somatic Mutations in Human Mesothelioma and Lessons from Asbestos-Exposed Genetically Engineered Mouse Models -- 9. Gene Signature of Malignant Pleural Mesothelioma -- 10. Cell Signaling and Epigenetic Mechanisms in Mesothelioma -- 11. 3D Models of Mesothelioma in the Study of Mechanisms of Cell Survival -- 12. Biomarkers of Response to Asbestos Exposure -- 13. Surgery Approaches in Mesothelioma -- 14. Radiotherapy and Photodynamic Therapy for Malignant Pleural Mesothelioma -- 15. Standard Chemotherapy Options and Clinical Trials of Novel Agents for Mesothelioma -- 16. Immunotherapeutic Approaches to Mesothelioma -- 17. Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections -- 18. The Patient's Experience of Malignant Mesothelioma.

Format: e-Book

Location: Online

Caring for Patients with Mesothelioma : Principles and Guidelines

https://libcat.nshealth.ca/en/permalink/provcat44381

Mary Hesdorffer, Gleneara E. Bates-Pappas, editors. --Cham: Springer , c2019.

Available Online: View e-Book

Location: Online

This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos r…

Available Online: View e-Book

Other Authors: Hesdorffer, Mary; Bates-Pappas, Gleneara E.

Responsibility: Mary Hesdorffer, Gleneara E. Bates-Pappas, editors

Place of Publication: Cham

Publisher: Springer

Date of Publication: c2019

Physical Description: 1 online resource (x, 239 p.) : 54 illus., 46 illus. in color

ISBN: 9783319962443; 9783319962436 (Print ed.); 9783319962450 (Print ed.)

Subjects (MeSH): Mesothelioma - therapy; Patient Care Planning

Specialty: Pulmonary Medicine

Abstract: This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.

Contents: Part I: Mesothelioma Treatment -- 1. History of Pleural Surgical Treatment -- 2. History Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis and Evolution and Contemporary Application in Peritoneal Mesothelioma -- 3. Cytoreductive Surgery and Intraperitoneal Chemotherapy for Treatment of Malignant Peritoneal Mesothelioma -- 4. Radiation Therapy -- Part II: Therapeutic Treatments: Chemotherapy, Biotherapy, and Immunotherapy -- 5. Chemotherapy and Standard Treatment Options -- 6. Caring for Patients During and After Immunotherapy Treatment -- 7. Biotherapy Treatment: Mesothelin-Targeted Therapies -- 8. Care of the Mesothelioma Patient Undergoing Extended Pleurectomy and Decortication -- Part III: Supportive Health Care for Treatment -- 9. Maintaining a Nutritional Diet During and After Active Treatment -- 10. Mesothelioma and Physical Therapy -- 11. Occupational Therapy and Mesothelioma -- 12. Respiratory Therapy and Pulmonary Rehabilitation for Mesothelioma Patients -- 13. Palliative Care Services for Mesothelioma Patients -- 14. Difficult Conversations and Survivorship -- 15. End-of-Life Care -- Part IV: Public Health Impact of Asbestos Worldwide -- 16. Public Health Impact of Asbestos Worldwide: What Is the Current Public Health Impact? -- Part V: The Future of Mesothelioma Research -- 17. Understanding Clinical Trials in Malignant Mesothelioma -- 18. The Future of Mesothelioma Research: Basic Science Research -- Part VI: Patient’s Perspective -- 19. The Impact of the Internet on Mesothelioma Patients: The Good, the Bad, and the Ugly -- 20. Patient Perspective on Mesothelioma Treatment.

Format: e-Book

Location: Online

Diffuse Malignant Mesothelioma

https://libcat.nshealth.ca/en/permalink/provcat39016

Timothy Craig Allen, editor. --New York, NY: Springer , c2015.

Available Online: View e-Book

Location: Online

This volume is the most up-to-date text available on diffuse malignant mesothelioma and includes all the newest imaging modalities, immunohistochemical features, and ever-expanding information on the molecular characteristics of the cancer. In-depth chapters contain fully referenced text as well as detailed tables and images. While the primary audiences for this book are pathologists and pathology residents, the broad examination of diffuse malignant mesothelioma, including its epidemiology, ma…

Available Online: View e-Book

Other Authors: Allen, Timothy Craig

Responsibility: Timothy Craig Allen, editor

Place of Publication: New York, NY

Publisher: Springer

Date of Publication: c2015

Physical Description: 1 online resource (xi, 142 p. : 56 illus., 46 illus. in color)

ISBN: 9781493923748; 9781493923731 (print ed.)

Subjects (MeSH): Mesothelioma - diagnosis; Mesothelioma - pathology

Abstract: This volume is the most up-to-date text available on diffuse malignant mesothelioma and includes all the newest imaging modalities, immunohistochemical features, and ever-expanding information on the molecular characteristics of the cancer. In-depth chapters contain fully referenced text as well as detailed tables and images. While the primary audiences for this book are pathologists and pathology residents, the broad examination of diffuse malignant mesothelioma, including its epidemiology, makes this book valuable to radiologists, surgeons, oncologists, and other clinical physicians and their residents as well. Written by experts in the field, Diffuse Malignant Mesothelioma is a concise yet comprehensive resource for clinicians involved in the management of one of the most widely recognized and feared cancers in the world.

Contents: Approaching the Diagnosis of Diffuse Malignant Mesothelioma -- Epidemiology -- Clinical and Radiologic Features -- Histology -- Immunohistochemistry -- Molecular Characteristics -- Therapy.

Format: e-Book

Location: Online

Malignant Mesothelioma

https://libcat.nshealth.ca/en/permalink/provcat30160

edited by Andrea Tannapfel. --Berlin, Heidelberg: Springer-Verlag , c2011.

Available Online: View e-Book

Location: Online

Available Online: View e-Book

Author: Tannapfel, Andrea

Responsibility: edited by Andrea Tannapfel

Place of Publication: Berlin, Heidelberg

Publisher: Springer-Verlag

Date of Publication: c2011

Series Vol.: 189

Series Title: Recent results in cancer research

ISBN: 9783642108624

Subjects (MeSH): Asbestos - adverse effects; Mesothelioma

Subjects (LCSH): Oncology; Pneumology

Format: e-Book

Location: Online

Malignant Mesothelioma : Advances in Pathogenesis, Diagnosis, and Translational Therapies

https://libcat.nshealth.ca/en/permalink/provcat28173

edited by Harvey I. Pass, Nicholas J. Vogelzang, Michele Carbone. --New York, NY: Springer Science+Business Media , c2005.

Available Online: View e-Book

Location: Online

Available Online: View e-Book

Author: Pass, Harvey I

Other Authors: Vogelzang, Nicholas J; Carbone, Michele

Responsibility: edited by Harvey I. Pass, Nicholas J. Vogelzang, Michele Carbone

Place of Publication: New York, NY

Publisher: Springer Science+Business Media

Date of Publication: c2005

ISBN: 9780387282749

Subjects (MeSH): Mesothelioma - diagnosis; Mesothelioma - pathology; Mesothelioma - therapy

Subjects (LCSH): Oncology; Pneumology; Thoracic surgery

Format: e-Book

Location: Online

Malignant Mesothelioma and Pseudomyxoma

https://libcat.nshealth.ca/en/permalink/provcat44067

Mikhail V. Kiselevskiy, Amir G. Abdulaev, Mikhail M. Davydov, editors. --Cham: Springer , 2019.

Available Online: View e-Book

Location: Online

This book covers different aspects of the rare neoplasms – malignant mesothelioma and pseudomyxoma peritonei. The monograph includes up-to-date information on etiology, pathogenesis and diagnostics of malignant mesothelioma and pseudomyxoma peritonei, as well as detailed description of surgical and combined treatment of patients with these diseases. The book comprises a large illustrative material presented by schemes and original micrographs that represent pathological and immunohistochemical …

Available Online: View e-Book

Other Authors: Kiselevskiy, Mikhail V.; Abdulaev, Amir G.; Davydov, Mikhail M.

Responsibility: Mikhail V. Kiselevskiy, Amir G. Abdulaev, Mikhail M. Davydov, editors

Place of Publication: Cham

Publisher: Springer

Date of Publication: 2019

Physical Description: 1 online resource (x, 121 p.) : 40 illus., 38 illus. in color

ISBN: 9783319995106; 9783319995090 (Print ed.); 9783319995113 (Print ed.)

Subjects (MeSH): Mesothelioma, Malignant; Pseudomyxoma Peritonei

Specialty: Medical Oncology; Pulmonary Medicine

Abstract: This book covers different aspects of the rare neoplasms – malignant mesothelioma and pseudomyxoma peritonei. The monograph includes up-to-date information on etiology, pathogenesis and diagnostics of malignant mesothelioma and pseudomyxoma peritonei, as well as detailed description of surgical and combined treatment of patients with these diseases. The book comprises a large illustrative material presented by schemes and original micrographs that represent pathological and immunohistochemical specific features of these malignancies, demonstrate the stages of surgical operations and hyperthermic intraperitoneal chemotherapy, and show the results of experimental studies. The book includes validated discussion on etiology and pathogenesis of malignant mesothelioma and pseudomyxoma peritonei, differential diagnosis and treatment of these diseases. The scope is really extensive and involves, for instance, a description of the technique of cytoreductive surgeries and regimens of intraperitoneal hyperthermic chemoperfusion, whereas a particular section discusses experimental ground for optimal regimens of hyperthermia, local chemotherapy and adoptive immunotherapy by cytokine induced killers. The final section presents the most recent data about perspective approaches for immunotherapy of malignant mesothelioma and pseudomyxoma peritonei with cell based technologies and target drugs including inhibitors of immune checkpoints. The co-authors of the book are leading specialists in this area, surgeons and scientists who present the results of their research along with the analysis of the state-of-the-art of this problem. The book is designed for a wide audience of students and professors of medical universities and schools, specialists of research and diagnostic centers, practical oncologists and immunologists, as well as doctors of different medical areas.

Contents: Mesothelioma and pseudomyxoma peritonei: incidence, etiology, diagnosis -- Pathology of selected primary and metastatic tumors of peritoneum -- Treatment of patients with pseudomyxoma peritonei and peritoneal mesothelioma -- Standardizing of mesothelioma and pseudomyxoma care -- Experimental substantiation of optimal regimes of hyperthermic peritoneal chemotherapy -- Immunotherapy of malignant peritoneal mesothelioma and pseudomixoma peritonei.

Format: e-Book

Location: Online

Mesothelioma : From Research to Clinical Practice

https://libcat.nshealth.ca/en/permalink/provcat44612

Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci, editors. --Cham: Springer , c2019.

Available Online: View e-Book

Location: Online

This book offers an updated review of malignant mesothelioma, including the latest advances in our understanding of its genetic control and molecular biology, as well as pre-clinical and clinical research. It also presents state-of-the-art diagnostic approaches and therapeutic options, and an open discussion on the future prospects for patient management. Malignant mesothelioma is an enormous global health problem related to asbestos exposure. Despite the best efforts of scientists and oncologi…

Available Online: View e-Book

Other Authors: Ceresoli, Giovanni Luca; Bombardieri, Emilio; D'Incalci, Maurizio

Responsibility: Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci, editors

Place of Publication: Cham

Publisher: Springer

Date of Publication: c2019

Physical Description: 1 online resource (xii, 340 p.) : 82 illus., 56 illus. in color

ISBN: 9783030168841; 9783030168834 (Print ed.); 9783030168858 (Print ed.); 9783030168865 (Print ed.)

Subjects (MeSH): Mesothelioma

Specialty: Pulmonary Medicine

Abstract: This book offers an updated review of malignant mesothelioma, including the latest advances in our understanding of its genetic control and molecular biology, as well as pre-clinical and clinical research. It also presents state-of-the-art diagnostic approaches and therapeutic options, and an open discussion on the future prospects for patient management. Malignant mesothelioma is an enormous global health problem related to asbestos exposure. Despite the best efforts of scientists and oncologists, the prognosis for those affected remains poor. Due to anatomical characteristics and non-specific symptoms, the diagnosis of mesothelioma at an early stage is often difficult, while surgery and radiotherapy are only of limited use, even if some multimodality approaches seem promising. In turn, medical treatments are sometimes successful in tumor control, but have little impact on overall survival. However, advances in our understanding of the disease’s biology, together with the availability of new drugs and combinations, make mesothelioma an essential and highly topical field for pre-clinical and clinical studies. This book is subdivided into four parts: epidemiology and preclinical data, diagnosis, therapy, and extrathoracic mesothelioma. It highlights the progress made in a variety of areas – e.g. in vitro and in vivo experimental models, genetics, environment, biomarkers, targeting agents, immunotherapy, metabolic imaging and ongoing clinical trials – and describes the standard clinical management of mesothelioma patients, including those with extra-thoracic localizations. Given its scope, the book offers an invaluable tool for researchers, oncologists and clinicians alike.

Contents: 1. Epidemiology of Mesothelioma -- 2. Asbestos and the Pathophysiology of Mesothelioma -- 3. Screening Issues in Exposed Subjects and Early Diagnosis -- 4. Genetics and Epigenetics of Mesothelioma -- 5. Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma -- 6. Preclinical Models in Mesothelioma -- 7. Pathological Diagnosis of Mesothelioma -- 8. Tissue and Circulating Biomarkers in Mesothelioma -- 9. Diagnostic Imaging of Mesothelioma -- 10. Measuring Malignant Pleural Mesothelioma -- 11. Role of Metabolic Imaging in Mesothelioma -- 12. Staging of Malignant Pleural Mesothelioma -- 13. Surgery and Multimodality Treatment in Malignant Pleural Mesothelioma -- 14. Role of Radiotherapy in Malignant Pleural Mesothelioma -- 15. Role of Chemotherapy in the Management of Malignant Pleural Mesothelioma -- 16. Targeting Angiogenesis in Malignant Pleural Mesothelioma -- 17. Targeted Therapies in Mesothelioma -- 18. Mesothelin-Targeted Agents in Mesothelioma -- 19. Immunotherapy of Mesothelioma: Vaccines and Cell Therapy -- 20. Immunotherapy, the Promise for Future of Mesothelioma Treatment? -- 21. Peritoneal Mesothelioma: Diagnosis and Management -- 22. Rare Localizations of Mesothelioma -- 23. Unmet Needs and Future Outlook of Mesothelioma Management.

Format: e-Book

Location: Online

Pathology of asbestos-associated diseases

https://libcat.nshealth.ca/en/permalink/provcat33340

Tim D. Oury, Thomas A. Sporn, Victor L. Roggli, editors. (Third edition) --Heidelberg: Springer , c2014.

Available Online: View e-Book

Location: Online

The third edition of Pathology of Asbestos-Associated Diseases builds on the success of the previous editions by fully updating knowledge on diagnostic and epidemiologic aspects and presenting important new insights derived from new epidemiologic studies and animal studies. Background information is first provided on the mineralogy of asbestos, occupational and environmental exposure, and asbestos bodies. The various diseases associated with asbestos exposure are then considered in turn, with d…

Available Online: View e-Book

Other Authors: Oury, Tim D; Sporn, Thomas A; Roggli, Victor L

Responsibility: Tim D. Oury, Thomas A. Sporn, Victor L. Roggli, editors

Edition: Third edition

Place of Publication: Heidelberg

Publisher: Springer

Date of Publication: c2014

Physical Description: 1 online resource (vi, 357 pages)

ISBN: 9783642411939 (electronic bk.); 9783642411922

Subjects (MeSH): Asbestos - adverse effects; Asbestosis - pathology; Lung Neoplasms - pathology; Mesothelioma - pathology; Pleural Diseases - pathology

Subjects (LCSH): Asbestosis - Complications - Cytopathology; Asbestosis - Complications - Cytodiagnosis; Asbestos - Carcinogenicity; Asbestos fibers - Analysis

Abstract: The third edition of Pathology of Asbestos-Associated Diseases builds on the success of the previous editions by fully updating knowledge on diagnostic and epidemiologic aspects and presenting important new insights derived from new epidemiologic studies and animal studies. Background information is first provided on the mineralogy of asbestos, occupational and environmental exposure, and asbestos bodies. The various diseases associated with asbestos exposure are then considered in turn, with detailed description and illustration of pathologic features as well as extensive discussion of etiology, epidemiology, differential diagnosis, treatment, and prognosis. Further chapters are devoted to cytopathology, experimental models of disease, and analysis of tissue mineral fiber content. In addition, the medicolegal issues relating to asbestos-associated diseases are analyzed from the point of view of both the plaintiff and the defendant. This book will be an essential reference for pathologists and an invaluable source of information for pulmonologists, radiologists, and occupational medical practitioners.

Contents: The Mineralogy of Asbestos -- Occupational and Environmental Exposure to Asbestos -- Asbestos Bodies and Non-asbestos Ferruginous Bodies -- Asbestosis -- Mesothelioma -- Benign Asbestos-Related Pleural Disease -- Carcinoma of the Lung -- Other Neoplasia -- Cytopathology of Asbestos-Associated Diseases -- Experimental Models of Asbestos-Related Diseases -- Analysis of Tissue Mineral Fiber Content -- Medicolegal Aspects of Asbestos-Related Diseases: A Plaintiff's Attorney's Perspective -- Medicolegal Aspects of Asbestos-Related Diseases: A Defendant's Attorney's Perspective.